Home › Funds › Jupiter Research Capital (Asia) Ltd › JNJ

Jupiter Research Capital (Asia) Ltd position in JNJ

JOHNSON & JOHNSON · Health Care

Jupiter Research Capital (Asia) Ltd reported holding 43,775 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$11.6M, representing 1.27% of its reported portfolio and ranking #11 among its reported holdings. Jupiter Research Capital (Asia) Ltd has disclosed JNJ holdings in 2 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)43.77K sh
Reported value held$11.59M
Portfolio Weight1.27%
First reportedQ4 2025
Last changeNew
Updated2026-11-21

Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR

How Jupiter Research Capital (Asia) Ltd's JNJ position evolved

Jupiter Research Capital (Asia) Ltd first disclosed a stake in JNJ in Q4 2025 at 11,309 shares (US$2.3M). The position peaked in Q3 2026 at 43,775 shares, worth US$11.6M. Across 2 filings, Jupiter Research Capital (Asia) Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 43,775 shares valued at US$11.6M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 11.31K $2.34M New
Q3 2026 43.77K $11.59M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$55.52B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Jupiter Research Capital (Asia) Ltd held JNJ?

Jupiter Research Capital (Asia) Ltd has disclosed JNJ holdings in 2 of the last 4 reported quarters, going back to Q4 2025.

What is Jupiter Research Capital (Asia) Ltd's current position in JNJ?

As of Q3 2026, Jupiter Research Capital (Asia) Ltd holds 43.77K shares of JNJ (JOHNSON & JOHNSON), valued at $11.59M, representing 1.27% of its reported portfolio and ranking #11.

Has Jupiter Research Capital (Asia) Ltd been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Jupiter Research Capital (Asia) Ltd newly opened its position in JNJ. The position peaked in Q3 2026 at 43.77K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.